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ABSTRACT
This study evaluated possible sex differences in intracellular heat shock protein
72 (Hsp72), intracellular cytokines, and extracellular Hsp72 (eHsp72) before and after
exercise in the heat. Nine non-heat acclimated women (W) (age 23 ± 3, BF 21 ± 2%,
VO2max 58 ± 5 ml/kgFFM/min) and nine non-heat acclimated men (M) (age 25 ± 5, BF 12
± 5%, VO2max 60 ± 7 ml/kgFFM/min) completed 2 treadmill bouts at 60% VO2max for 60
min in a 42°C, 20% RH environment. The W had normal menstrual cycles and were
tested in counterbalanced order during follicular (fol) and luteal (lut) phases. M and W’s
duplicate trials were separated by 12 ± 2 days. Blood samples were drawn pre, 0, 1, and
4 hrs post-exercise. Mononucleated cells were analyzed for Hsp72, IL-1ra, IL-6, and
TNF-α using flow cytometry. eHsp72 was analyzed using ELISA. In trial 1, Hsp72
content increased in M by 37% 4 hrs post exercise (p<0.05), but did not change
significantly in W at any time after exercise. When Hsp72 expression was normalized to
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baseline, M expressed greater Hsp72 than W (p<0.05) after exercise. Baseline Hsp72
increased by 26% in M from trial 1 to trial 2 (p<0.05), but this effect did not occur in W.
eHsp72 did not change after exercise, but there was a main effect for M having higher
levels than W (p<0.05). While cytokines did not change during exercise, W consistently
expressed less IL-1ra than M (p<0.05). IL-6 and TNF-α were higher in the fol than lut
phase at 4 hrs post exercise (p<0.05). Our findings suggest that unacclimated M and W
differ in their expression of Hsp72 and eHsp72 after exercise in the heat. M up-regulate
Hsp72 after a single bout of exercise in the heat, which persisted for 12 days, suggesting
an acquired cellular thermotolerance. The inhibition of Hsp72 expression in W after
exercise could be due to a known effect of estrogen to stabilize the cell membrane or to
its action as an anti-oxidant.

vi

TABLE OF CONTENTS
Abstract.............................................................................................................................. v
CHAPTER I .......................................................................................................................1
Introduction............................................................................................................. 1
Scope of Study ........................................................................................................ 4
Cellular Actions of Estrogens ................................................................................. 6
Purpose of Study ..................................................................................................... 7
Hypothesis............................................................................................................... 8
Limitations ............................................................................................................ 10
Significance of Study............................................................................................ 11
Definitions............................................................................................................. 11
References............................................................................................................. 13
CHAPTER II: REVIEW MANUSCRIPT ....................................................... 18
Abstract ................................................................................................................. 19
Introduction: Exercise as a Model to Assess Immune Function........................... 19
Sex Differences in Immune Function in Non-Exercising Conditions ...................21
Sex Differences in Immune Response to Exercise: Inoculation Studies .............. 22
Sex Differences in Cytokine Response to Exercise.............................................. 23
Sex Differences in Leukocyte Response to Exercise............................................ 28
Sex Differences in Natural Killer Cell Response to Exercise................................31
Sex Differences in Neutrophil Response to Exercise ........................................... 32
Potential Mechanism of Action for Sex Differences in Immune Response to
Exercise................................................................................................................. 34
vii

Future Research Considerations and Conclusions................................................ 36
References............................................................................................................. 39
CHAPTER III: RESEARCH MANUSCRIPT............................................................. 47
Abstract ................................................................................................................. 48
Introduction........................................................................................................... 50
Materials and Methods.......................................................................................... 51
Subjects ..................................................................................................... 51
Preliminary Testing................................................................................... 51
Experimental Design................................................................................. 52
Experimental Protocol .............................................................................. 52
Blood Analysis: Hsp72 ............................................................................. 53
Blood Analysis: Cytokines ....................................................................... 54
Blood Analysis: eHsp72 ........................................................................... 55
Blood Analysis: Estrogen and Progesterone............................................. 55
Statistical Analysis.................................................................................... 56
Results................................................................................................................... 57
Subject Characteristics.............................................................................. 57
Exercise Response .................................................................................... 57
Hormones During the Menstrual Phase .................................................... 58
Effect of Exercise on Hsp72 and Cytokines ............................................. 59
Effect of Sex on Hsp72 and Cytokines ..................................................... 61
Effect of Menstrual Phase on Hsp72 and Cytokines ................................ 63
Discussion ............................................................................................................. 64

viii

Hsp72 ........................................................................................................ 65
Cytokines .................................................................................................. 67
eHsp72 ...................................................................................................... 69
Conclusion ............................................................................................................ 69
References............................................................................................................. 71
CHAPTER IV: SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS .... 75
Summary Hypotheses ........................................................................................... 75
Limitations ............................................................................................................ 76
Conclusion and Applications ................................................................................ 77
Recommendations................................................................................................. 78
Detailed Flow Cytometry Protocol ....................................................................... 78
References............................................................................................................. 81
APPENDICES
Appendix A: Informed Consent............................................................................ 82
Appendix B: Health History Questionnaire.......................................................... 89

ix

Chapter I
Introduction
The heat shock protein family (HSP) is a family of highly conserved proteins located in
all cells. HSPs demonstrate cytoprotective properties and are categorized according to
their molecular weight. In a non-stressed cell, HSP are bound to heat shock factor (HSF)
in the cytosol of the cell. However, upon stressful stimuli, HSPs are released from HSF
allowing HSP to bind to the damaged protein and permitting HSF to be translocated to
the nucleus to begin transcription of heat shock 72 protein (Hsp72) (Ellis, 1996). Hsp72
is the most inducible form of HSP (Kregel 2002). The induction of Hsp72 can arise from
a variety of stressors that include oxidative stress (Adrie 2000), energy depletion
(Sciandra 1983), ischemia reperfusion injuries (Marber 1995), or hyperthermia (Mizzen
1988), among others. Stressors can result in the release of Hsp72 into the circulation
typically from the splanchnic tissue (Febbraio 2002), but can also be released by other
healthy (Lancaster 2005) and necrotic cells (Basu 2000). Extracellular Hsp72 (eHsp72)
acts as a danger signal activating the immune system (Asea 2002), stimulating
inflammation (Dybdahl 2002), and it is sometimes used as an indirect marker of heat
stress (Ruell 2006).

Hsp72 has been implicated in cellular protection against increases in core temperature
with exercise in the heat. This increased protection is known as acquired thermotolerance
and is defined as a single exposure to heat stress that leads to future protection. This
process involves an increased basal expression of intracellular Hsp72 (Landry 1982, Li
1982). When comparing heat tolerant to heat intolerant subjects, those who were heat
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intolerant were found to have lower post exercise intracellular Hsp72 levels in
lymphocytes than heat tolerant subjects. Heat intolerant subjects also demonstrated
decreased heat shock factor-1 (HSF-1) in lymphocytes, the primary transcription factor
for Hsp72, throughout exercise and during recovery (Moran 2006).

There is increased gut permeability with exercise in the heat (Rowell 1973). Hsp72 may
be responsible for a greater heat tolerance due to its role in reducing heat-induced gut
permeability and in decreasing pro-inflammatory cytokines released from peripheral
blood mononucleated cells (PBMC) (Snyder 1992). Specifically, due to the increased
demand of blood flow to the skin and active skeletal muscles during exercise in the heat,
blood is shunted away from the gut and blood flow to the splanchnic region receives less
than 20% of its normal blood flow (Rowell 1973). This decreased blood flow can cause
ischemia and increased permeability of the gut (Rowell 1973). Increased gut permeability
can allow lipopolysacharide (LPS) to enter the systemic circulation. When LPS, a gramnegative bacteria found in the intestinal lumen enters the systemic circulation, it forms a
complex with lipopolysacharide binding protein (LBP) that binds to toll-like receptors
(TLR) on immune competent cells (Schumann 1992). The binding of this complex to its
receptor activates NF- kb and the synthesis of pro-inflammatory cytokines in circulating
leukocytes (Liu 2006). Endotoxin release from the gut and its subsequent inflammatory
cascade can lead to systemic inflammation and eventually multiple organ dysfunction
syndrome (Chen 2005). This is one of the main causes of heat stroke (Leon 2007, Lim
2006). Hsp72 has been shown to decrease gut permeability by maintaining intestinal tight
junctions (Dokladney 2006), suggesting a potential role of Hsp72 in decreasing intestinal
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permeability. This decrease in intestinal permeability may limit LPS release into the
circulation. LPS tolerance, the diminished inflammatory response to repeated LPS
exposure, has been linked to heat tolerance (Selkirk 2008). Trained subjects demonstrated
greater intracellular Hsp72 in monocytes during heat stress than untrained subjects, and
this corresponded with greater LPS tolerance and decreased monocyte apoptosis at
exhaustion (Selkirk 2009). Furthermore, NF-kb activation occurred at higher core
temperatures in trained subjects compared to untrained, suggesting an important role of
Hsp72 in heat acclimation and cellular heat tolerance. (Selkirk 2008). Taken together, the
increased expression of Hsp72 may serve a two-fold purpose: 1) Increased Hsp72 in the
gut cells may decrease permeability by maintaining tight junctions and limit LPS
movement through the gut. This could increase tolerance to exercise in the heat. 2)
Hsp72 may decrease pro-inflammatory cytokines released from PBMCs by inhibiting
NF-kB activation and the subsequent release of pro-inflammatory cytokines.

Serum Hsp72 (eHsp72) acts as a danger signal activating the immune system (Asea
2002) and promotes the release of pro-inflammatory cytokines (Dybdahl 2002). eHsp72
can bind to TLR on antigen presenting cells stimulating the release of cytokines (Asea
2008) and are also involved in the maturation of dendritic cells (Wang 2005). It is
thought that the release of Hsp72 comes from the splanchnic tissue (Febbraio 2002) and
not the exercising muscle. However, the release of Hsp72 can come from healthy PBMC
(Hunter-Lavin 2004) and B cells (Clayton 2005), and under situations of extreme stress,
Hsp72 can also be released from necrotic cells (Basu 2000). eHsp72 can serve as a
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marker of heat illness as higher levels of eHsp72 were detected in runners with severe
heat illness (Ruell 2006).

Scope of the Study
Given that increased Hsp72 expression may confer protection against heat-induced
perturbations, it may be significant that animal studies have shown a difference in the
expression of Hsp72 between sexes. Under resting conditions, basal levels of Hsp70 in
cardiac and renal tissue are higher in female compared to male rats (Voss 2003, Fekete
2006). However, in response to an assortment of stressors in a variety of tissues, male
animals are able to express higher Hsp72 levels than females. Specifically, cardiac tissue
of male rats exhibited a two-fold higher increase in Hsp70 after one hour of running
compared to their female counterparts (Paroo 2002a). Whole body hyperthermia (43°C,
20 min) resulted in male rats demonstrating a greater expression of cardiac Hsp72 after
heating than females (Shinohara 2004). In both studies, ovariectomized female rats
displayed similar post stress Hsp70 levels as males. Ovariectomized rats treated with
estrogen showed decreased Hsp70 similar to intact females. Furthermore, both studies
revealed that males, who induced a larger expression of cardiac Hsp70 than intact
females, had better protection against an ischemic insult to the heart given after the
stress. It should be noted that the ischemic insult in the above experiments were
performed on euthanized rats 24 hrs after exercise. Also, the gastrocnemius muscle of
male rats doubled the Hsp70 protein content and increased Hsp70 mRNA almost 9 fold
after 60 min of running, while female rats did not increase either Hsp70 content or
mRNA. Furthermore, placebo treated ovariectomized animals revealed higher post
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exercise Hsp70 content and mRNA levels than estrogen treated animals (Paroo 2002b).
In response to acute tail shock, the pituitary gland, mesenteric lymph nodes, and liver of
male rats had higher tissue content of Hsp72 levels post stress than females, while the
adrenal glands, spleen, and heart did not express a sex specific response. Moreover, there
was no fluctuation in Hsp72 expression at rest or in response to stress in any of the
tissues surveyed across the estrous cycle (Nickerson 2006). Little is known about sex
differences in Hsp72 expression in leukocytes after exposure to heat.

Based upon the above results in animals, the presence or absence of estrogen may
influence both the basal and the stress response of Hsp72. Ovariectomized rats treated
with estrogen had greater basal Hsp70 expression in the soleus and less Hsp70 expression
after 90 min of downhill running compared to rats treated with progesterone or sham
(Bombardier 2009). Such results suggest that estrogen may be the primary sex-specific
hormone responsible for the increased Hsp70 expression at rest and the blunted Hsp70
response after exercise. An increased basal expression of Hsp70 may reduce the muscle’s
stress-response to downhill running and thus limit the need for additional Hsp70
production after the stress (McArdle 2004).

The anti-oxidant actions of estrogen could be a factor involved in the blunted Hsp70
response to stress. In skeletal muscle, estrogen has been shown to be a powerful
antioxidant (Tiidus 1999) and a vital cell membrane stabilizer (Whiting 2000). Estrogen
can be directly incorporated into the cell membrane, and this can serve to fortify the cell
(Kendall 2002). Stabilizing the cell membrane has been shown to maintain calcium
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homeostasis, which can decreases calpain activity (Belcastro 1998). Calpian activation
leads to neutrophil infiltration and oxidative stress (Stupka 2001). Thus, estrogen may
protect the cells during exercise against oxidative damage (Tiidus 2001), potentially
resulting in less tissue damage and a blunted Hsp70 inflammatory response.

Taken together, the results from animal studies suggest two things regarding Hsp and
estrogen: 1) Estrogen may be responsible for the increased basal expression of Hsp72 in
certain tissues (cardiac, renal, skeletal muscle) and 2) because of the protective antiinflammatory effect of estrogen, the expression of Hsp72 may be reduced after exposure
to a severe stress, such as unaccustomed or high-intensity exercise. In addition, estrogen
could be protecting the cell from perturbations that would otherwise result in increased
expression of Hsp72. As a result, females may have a smaller induction of Hsp72 in
response to a stress than males.

Cellular Actions of Estrogens
The increased basal expression of Hsp70 seen in females may be due to estrogen’s
interaction with HSF-1, the key transcription factor for HSP. Estrogen can initiate the
Hsp72 cascade through HSF-1. Ex-vivo treatment with 17-b estradiol activated HSF-1
and led to increased expression of Hsp72 in male and female cardiac myocytes from rats
(Hamilton 2004, Knowlton 2001). It has been shown that Hsp90 forms a complex with
HSF-1 and the intracellular estrogen receptor. Treatment with estrogen disassociates
HSF-1 from Hsp90 allowing it to activate the transcription of Hsp72 (Knowlton 2001).
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The exact mechanism behind the relationship between estrogen and the blunted Hsp70
response to stress is currently not known. However, it has been suggested that estrogen
mediates its effect on Hsp70 through a nongenomic hormonal pathway. Treating animals
with tamoxifen, a known estrogen receptor agonist, showed the same blunted post
exercise Hsp70 expression as ovariectomized animals treated with 17β and 17α estradiol
(Paroo 2002b). Since tamoxifen, 17β, and 17α estradiol all acted to suppress the post
exercise expression of Hsp70, researchers suggest that these estrogen related compounds
stabilized the cell membrane and attenuated oxidative stress (Wiseman 1993). As
described above, stabilizing the sarcolemma protects the cell against exercise-induced
damages and could result in a blunted Hsp72 expression.

Purpose
Currently, there are no human studies that have tested for possible sex differences in the
stress response of Hsp72. Therefore, we aim to compare the expression of intracellular
Hsp72 and eHsp72 at rest and in response to exercise in the heat in men and women.
Furthermore, we will examine if females in follicular and luteal phases of the menstrual
cycle differ in their amount of Hsp72 expressed at rest and in response to exercise in the
heat. Since Hsp72 mediates inflammatory cytokine production, we will also compare the
responses of intracellular inflammatory markers (TNF-α, IL-1ra, and IL-6) between men
and women, and between women in follicular (low estrogen) versus luteal (high estrogen)
phases of their menstrual cycle.
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Hypothesis
In this study we will test the following hypotheses:

1. Women will have higher basal levels of intracellular Hsp72 than men.
Results from animal studies have shown that estrogen is associated with
increased basal Hsp72. For our studies we will obtain blood samples from
men and women matched for age and fitness. We will assess Hsp72 levels in
PBMC.

2. In response to a severe exercise stress (60 minutes of treadmill exercise at
60% VO2peak in the heat), men will express greater amounts of Hsp72.
In animal studies, estrogen has been shown to protect cells from stressors that
are known to increase Hsp72 production. Also, estrogen causes higher
baseline levels of Hsp72, and thus possibly limits the need for increased
production during a stressor. Therefore, we predict that increases in Hsp72
in PBMC after a severe exercise stress will be smaller in women than men.

3. Intracellular Hsp72 levels will be higher at baseline in women during the
luteal phase of their menstrual cycles, but in response to severe exercise the
expression of Hsp72 will be blunted in luteal compared to the follicular phase.
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Since estrogen is higher in the luteal phase, women will express higher
baseline Hsp72 compared to the follicular phase, when estrogens are
minimal. After exercise, women in the luteal phase will have a smaller
increase in intracellular HSP72 due to the protective effects of the estrogens.

4. Pro-inflammatory cytokines (TNF-α) will be reduced in conditions where
intracellular Hsp72 is elevated.
Since men have a greater Hsp72 response to exercise, they will express less
TNF-α and IL-6 than women after exercise. Also, since women in the
follicular phase have a greater Hsp72 response to exercise they also will have
a greater inflammatory response compared to during the luteal phase.

5. There will be no difference between groups in eHsp72. eHsp72 is released
with exercise, but this process does not appear to be mediated by estrogen.
eHsp72 has been shown to be released from the liver with exercise. There is no
animal or cell data that has examined how eHsp72 differs betweens sexes.
Further, more eHsp72 is released with heat illness. There is no research to
suggest that women are more inclined to experience heat illness symptoms than
men, therefore we expect no difference in eHsp72 between sexes.

To confirm the above hypotheses, healthy men and regularly menstruating women will
perform two bouts of treadmill running in a hot environment (42°C, 30% RH). All
subjects will be un-acclimated to the heat and data collection will occur in the fall and
9

winter months. The men and women will be matched for age, fitness level, and will
exercise at a similar relative exercise intensity (60% VO2peak) for 60 minutes. Women
will exercise during their follicular and luteal phases, and the menstrual phase order will
be counterbalanced. Men will exercise on two occasions separated by two weeks.
Venous blood samples will be obtained at rest before exercise, immediately post exercise,
1, and 4 hrs after exercise. Hsp72 and inflammatory cytokines will be determined from
PBMC cells by flow cytometry and extracellular Hsp72 will be determined by ELISA
kits.

Limitations
The vast majority of studies that have sought to examine differences in Hsp72 expression
between sexes have quantified Hsp72 in tissues (animals) or with muscle biopsies
(humans). In this study we will quantify Hsp72 expression in PBMCs and in the plasma.
Therefore, an assumption of our study is that the Hsp72 expressed in circulating
lymphocytes gives us an accurate representation of changes that are occurring in other
tissues of the body.

Our subjects will be tested during the time of year when we assume they are not heat
acclimated. Once acclimated, cellular levels of Hsp72 may be up-regulated and the
differences in Hsp72 between men and women, or between follicular and luteal phase,
could be lost.
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We are testing college age, healthy and relatively fit men and women. Less fit
individuals may have a different Hsp72 response: such as lower basal levels of Hsp72
and a greater stress response (Gjovaag 2006).

We are examining the stress response to exercise in the heat. Although there is evidence
of carry-over for the protective function of Hsp72 to other forms of stress, our sex
difference may only apply to this specific form of stress.

Significance
If females have a blunted increase in Hsp72 during exercise and heat stress, they may be
more susceptible to cellular injury. Specifically, a decreased synthesis and release of
Hsp72 might increase susceptibility to heat or impair their ability to become heat
acclimated. Alternatively, sex differences in the Hsp72 response to stress may highlight a
novel method of acquired thermotolerance if Hsp72 is not needed to protect cells from
heat-induced perturbations.

Definitions
Luteal phase testing: 19-22 days after the onset of bleeding for a normal 28 day cycle
(Timmons 2005) with values >500 pmol/L and progesterone values > 4 nmol/L.

Follicular phase testing: 3-8 days after the onset of bleeding for a normal 28 day cycle
(Timmons 2005). Estrogen values between 100-500 pmol/L and progesterone values
between 1-4 nmol/L.
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Core temperature: internal temperature measured rectally with the thermistor placed 810 cm past the anal sphincter. Rectal temperature was used because subjects were given
water during exercise. If core temperature was measured in the esophagus, then
consuming water would alter the temperature being recorded.

Peripheral blood Mononucleated cell (PBMC): Blood cells with a round shaped
nucleus. These include lymphocytes, monocytes, macrophages, and granulocytes.

Pro-inflammatory cytokines: Tumor necrosis factor- a (TNF-a) was measured in PBMC
before and after exercise.

Anti-inflammatory cytokines: interleukin -1 receptor antagonist (IL-1ra) and interleukin6 (IL-6) were measured in PBMC before and after exercise.

Hydration: Urine assessments of hydration will occur prior to each exercise test.
Subjects will be considered hydrated enough to begin the test if their urine osmolality is
below 800 mOsm/kg.
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A Review: Sex Differences in Immune Function After Aerobic Exercise

Abstract
When menstrual phase and oral contraceptives are controlled for, males and females
display marked differences in immune response to an exercise stress. In highly
controlled research studies, sex differences in immune cell changes, cytokine
alterations, along with morbidity and mortality after inoculation are apparent.
Exercise has been hypothesized to serve as a model of various clinical stresses by
inducing similar hormonal and immunological alterations. Thus, a greater
understanding of sex differences in post exercise non-specific immune function may
provide insight into more effective clinical approaches and treatments. This paper
reviews the recent evidence supporting sex differences in post exercise immune
response and highlights the need for greater control when comparing the post
exercise immune response between sexes.

Introduction: exercise as a model to assess immune function
Exercise modulates the non-specific (innate) (52) and specific (acquired or adaptive)
(12) arms of the immune system with an intensity dependent response. Moderate
bouts of exercise have been shown to enhance immunity (51). However, intense
exercise depresses the immune system (52, 8). More specifically, during moderate
and intense bouts of exercise there are transient increases in circulating pro- and antiinflammatory cytokine levels (55), concentration of lymphocytes and lymphocyte
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sub-sets (46), and macrophage activity (22). Recently, researchers (75, 76, 9, 53) have
suggested there are sex differences in the immune response to moderate and intense
exercise.

Exercise has been hypothesized to serve as a model for certain clinical stresses. In a
review article, Dr. BK Pederson wrote:
“Physical exercise can be regarded as a prototype of physical stress. Many
clinical physical stressors (e.g. surgery, trauma, burn, sepsis) induce a pattern
of hormonal and immunological responses that have similarities to that of
exercise (60).”

Clinical physical injury, similar to exercise injury, displays marked sex differences
(4). For example, females have higher levels of mortality than males in response to
burns of similar size (31). Females have a lower incidence of multiple organ
dysfunction syndrome (MODS) and sepsis in response to shock compared to males
(17). It is thought that the disparity in sex outcomes results from interactions of sex
hormones with various aspects of the immune system. Since exercise induces similar
immune response, it may provide a useful model to study sex differences in immune
response to clinical stressors. However, to understand this relationship, studies that
control for menstrual phase, oral contraceptive (OC) use, and fitness levels between
men and women are needed. The focus of this review will be to discuss what is
currently known about sex differences in non-specific immune responses to exercise.
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This review will consist of both animal and human studies that have examined the
post exercise immune response.

Sex Difference in Immune Function in Non-Exercising Conditions
Several aspects of immunity have marked sex differences in non-exercising
conditions. T cells, macrophages, and monocytes possess estrogen receptors (4) with
two different subtypes, ERα and ERβ (61). ERα is mainly found in the uterus and
mammary glands, while ERβ prevails in the central nervous, cardiovascular, and
immune systems (32). Through these receptors, estrogen led to greater survival
against herpes simplex virus 1 (HSV-1) in inoculated rats (9). In addition, in vitro
stimulation of lymphocytes with phytohemagglutinin, a toxin used to elicit cytokine
production from immune competent cells, found that females produce more Th2 (IL4, IL-10) cytokines than males (29). Th2 cytokines are responsible for secretion of
antibodies and this may play a role in the higher incidence of autoimmune diseases in
women (85). Furthermore, females have a higher percentage of T lymphocytes within
the total lymphocyte pool (5), and have more active circulating polymorphonuclear
leukocytes (neutrophils) and macrophages (64, 65). Overall, physiologic levels of
estrogen stimulate humoral and cell-mediated immune responses, but large increases
in estrogen (either from pregnancy or supraphysiologic doses) can suppress cellmediated immunity (54). Taken together, results imply that females of reproductive
age have a more active immune system than age matched males. This could account
for females having a lower incidence of, and mortality rates from, certain types of
infection (bacteria septlcemai, pneumonia/influenza, bacterial meningitis) (28) and
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lower rates of atherosclerosis (79). Similarly, this could also explain the increased
incidence of autoimmune diseases.

Sex Difference in Immune Response to Exercise: Inoculation Studies
Inoculating animals with viruses has previously been used as a model to study upper
respiratory infections in animals by inducing illness (33). Inoculation purposefully
infects the animal by transferring the causative agent into the animal. In this manner,
whole body responses can be measured after inducing a specific illness. With this
methodology, female mice experienced lower mortality after intranasal inoculation
with herpes simplex virus 1 (HSV-1) at rest and after exercise than males. HSV-1
was delivered after the third bout of running to exhaustion or after 3 non-exercising
control sessions. Though exercise resulted in greater morbidity (illness symptoms)
than control, both sexes experienced the same degree of morbidity. Despite males and
females having a similar rate of infection by HSV-1 after inoculation, fewer females
died (9). Similarly, female mice that exercised at a moderate intensity had a greater
macrophage resistance to HSV-1 than their male counterparts (8). However, both
males and females experienced suppressed macrophage function after exhaustive
exercise, and experienced this suppression to a similar degree. Thus, it is plausible
that the decreased mortality after HSV-1 inoculation seen in female mice may be due
to increased macrophage function. Since more females survived HSV-1 inoculation
than males, the presence of estrogen could be an important determinant of this
response. However, ovariectomized mice supplemented with estrogen experienced
higher mortality than intact female mice after HSV-1 inoculation (7). Despite the
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better protection of intact mice, there was only a trend (p=0.1) toward intact females
having greater macrophage resistance than the estrogen treated ovariectomized group.
Therefore, the authors suggested that antiviral macrophage resistance is not
responsible for the lower mortality (7). Since estrogen supplementation did not
restore the protective effects of intact mice, other female hormones could be
responsible for this added fortification of female mice. Taken together, animal
research with HSV-1 inoculation demonstrates that male and female mice are equally
susceptible to an infection at rest or after exhaustive exercise. However, more
females survive. The greater macrophage activity may be responsible for this effect,
but future studies should incorporate other immune parameters. The mechanism
behind greater female survival with HSV-1 may be related to other ovarian hormones
besides estrogen.

Sex Difference in the Cytokine Response to Exercise
The local response to a tissue injury involves the release of cytokines. Cytokines are
released from the site of inflammation. The local response of cytokine release is
supplemented by the release of cytokines from the liver, termed the acute phase
response. The acute phase cytokines are TNF-α, IL-1β, and IL-6. These proinflammatory cytokines cause the movement of lymphocytes, neutrophils, and
monocytes to the injured site. These leukocytes ultimately infiltrate the damaged
muscle and serve to repair the tissue (2). Initially, exercise leads to increased release
of pro-inflammatory cytokines (TNF-α, IL-1β,) and this is counteracted quickly by
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the release of cytokine inhibitors (IL-1ra, TNF receptors) and anti-inflammatory
cytokines (IL-10), which limit the inflammatory response of exercise (60).
With chronic exercise and training, there is a decrease in cytokine production during
an acute bout of exercise (69). Decreased cytokine release may contribute to
immunosuppression and lead to a greater risk of bacteria and infection that is often
evident in endurance-trained athletes (51). However, this decrease in inflammation
could be a key link between exercise and health through a possible reduction in the
risk of chronic disease.
Generally, cytokines are released after prolonged exercise or exercise that causes
muscle damage (10, 60). The intensity and duration of exercise, along with fitness
level, determines the cytokine profile (30). Interestingly, exercise does not cause an
alteration in pro-inflammatory gene expression in peripheral blood mononucleated
cells (PBMC) (81), suggesting that this is not a primary site for cytokine release.
Recently, researchers demonstrated IL-6 is released from the exercising muscle (38,
67). IL-6 can increase 100 fold after exercise making it the most responsive cytokine
to exercise and perhaps underscoring its biological significance. IL-6 has been shown
to regulate metabolic factors such as glucose uptake and fatty acid oxidation (59).
Recently, IL-6 released from the exercising muscle has been shown to have antiinflammatory properties through its up-regulation of anti-inflammatory cytokines IL1ra (56) and IL-10 (55), in addition to inhibiting TNF-α release (66). For a detailed
review of IL-6 and exercise, see Febbraio, 2005 (21).
Sex differences in the regulation of cytokines have been previously demonstrated in
non-exercising conditions. After lymphocytes were stimulated with
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phytohemaglutinin, a toxin used to elicit cytokine production from immune
competent cells, a greater Th1 profile, characterized by increased release of IFN-γ
and IL-2, was shown in lymphocytes drawn from men compared to women. Women
possessed a greater Th2 cytokine release (IL-4, IL-10) than men, but there were no
differences across the menstrual cycle (29). Th2 cytokines are responsible for
humoral mediated immunity and lead to increased secretion of antibodies. Similarly,
IL-1 release from mononucleated cells is lower in males and is menstrual phase
dependent in females(44). More specifically, the balance of the IL-1 family (IL-1-α,
IL-β - agonist, IL-1ra – antagonist) is menstrual phase dependent. The ratio of
agonist (IL-1-α, IL-β) to antagonist (IL-1ra) was equal during the follicular stage, but
the agonist was ~45% higher in the luteal phase. Thus, the activity of IL-1α/β was
greater in the luteal phase. IL-1β may influence reproductive functions like
endometrial development and preparing the birth canal for parturition. IL-1β has also
been shown to block leutenizing hormone and ovulation in rats (28). After traumahemorrhage injury, ovariectomized mice had decreased cytokine expression (IL-2,
IL-3, and IFN-γ) from macrophages compared to ovariectomized mice treated with
17-β estradiol. The estradiol treated group maintained cytokine release after injury
and this suggests that estrogen is capable of preventing immunosuppression that had
been previously demonstrated with male mice and enhancing survival (41).
Currently, there are a handful of studies that have compared the cytokine response to
exercise between sexes. There was no difference reported in serum IL-10, IL-1ra, IL6, and IL-8 between men and women immediately and 1.5 hours after completing a
marathon (50). The in-vitro production of IL-1, IFN-γ, and IL-4 from cultured whole
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blood showed no differences between genders in response to continuous incremental
cycling at 55%, 70%, and 85% VO2peak (49). Similarly, 90 minutes of cycling at 65%
VO2max resulted in no difference in serum IL-6 levels between men and women (75).
There was however, a trend (p=0.06) of increased IL-6 in women who took OC and
those who were not taking OC and exercising in the follicular phase (75). The change
in IL-6 values could be due to altered carbohydrate (CHO) oxidation rates. It was
shown that whole body CHO oxidation during 50 min of cycling at 70-90% of lactate
threshold is higher in the follicular phase (89). This higher rate of CHO oxidation
could have lead to a greater depletion of CHO. In response to low CHO availability,
IL-6 production will increase (38). In contrast, Edwards found that 60 minutes after a
maximal cycling test, female IL-6 values were greater than men (18), although there
were no differences between genders at baseline, immediately, or 30 minutes post
exercise. At 60 minutes post exercise, the male IL-6 values decreased towards
baseline while the female values continued to rise. The exercise-induced IL-6
response is directly linked to the duration and intensity of exercise, along with the
number of muscle fibers recruited (increased release) and the fitness level of subjects
(decreased response) (57). Thus, methodological differences could account for the
current disparity in the literature regarding IL-6.

At the transcriptional level, Northoff et al found a gender and menstrual phase
difference in mRNA inflammatory gene expression in response to a 60 min run at
93% of the individual’s anaerobic threshold (53). Women in the luteal phase
demonstrated a greater condition of pro-inflammation than women in the follicular
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phase or men immediately after exercise. This pro-inflammatory state was
characterized by an increase in inflammatory genes (interferon-γ, IL-12 receptor β1,
and prostaglandin D2 receptor) and a decrease in anti-inflammatory genes (IL-6,
IL1R2, IL1-ra) in PBMC. The authors state that the increase pro-inflammatory
condition in the luteal phase could be a “mechanism designed to end a very early
pregnancy in case of major external stress input. After all, human females get a new
chance to conceive in the next month and nature may prefer to destabilize a
pregnancy under influence of stress rather than carry it on under high risk.”
Furthermore, women in the luteal phase regulated over 200 genes (129 genes upregulated, 143 genes down-regulated), while women in the follicular phase regulated
80 genes (48/32) and men regulated only 63 genes (34/29). Interestingly, post
exercise IL-6 mRNA was down- regulated in the luteal phase, while up-regulated in
the follicular phase after exercise. Future studies that control for menstrual cycle are
needed to assess the expression of the specific proteins before any conclusions can be
drawn.

Thus, in limited research on aerobic exercise, it appears the overall cytokine response
to exercise is not markedly different between sexes. However, few studies controlled
for either menstrual phase or oral contraception. Some work has demonstrated a
greater up-regulation of inflammation (129 genes up-regulated, 143 genes downregulated) in the luteal phase at the transcriptional level after exercise (53). Potential
sex differences in IL-6 may exist after maximal exercise (18) and further research is
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needed to confirm the IL-6 response at longer time points after exercise while
controlling for menstrual phase and oral contraceptive use.

Sex Differences in Leukocyte Response to Exercise
Moderate aerobic exercise results in a transient increase in both innate (monocytes,
macrophages, neutrophils, NK cells) and specific (B and T lymphocytes) cells of the
immune system. The effector cells of the innate immune system are monocytes,
macrophages, neutrophils, and a subset of lymphocytes called natural killer (NK)
cells. These cells represent the first line of defense against infections by neutralizing
microbes or pathogens that have entered the circulation through phagocytosis
(monocytes, macrophages, neutrophils) or by directly lysing the pathogen (NK cells).
T cells recognize specific antigens presented to them to create memory cells, and B
cells secrete antibodies to kill extracelluar pathogens. B cells are fundamental for
eradicating bacterial infections. The number of total leukocytes, lymphocytes,
granulocytes (neutrophils), and monocytes increase in a biphasic response (46). The
immediate increase of leukocytes is characterized by increases in lymphocytes,
monocytes, macrophages, and neutrophils, and is then followed by a delayed response
of additional neutrophils 2 hours post exercise (46, 87).

Both the duration and intensity of exercise combine to determine the specific increase
in leukocytes with exercise. Exercising for up to 30 minutes leads to increased
lymphocytes (CD4+T cells, CD8+T cells, CD19+ B cells, CD16+ NK cells, CD56+
NK cells), which return to baseline values within 10-30 minutes after cessation of
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exercise (46). Longer duration exercise requires longer time periods for leukocytes to
return to baseline. Specifically, CD8+ lymphocytes increase more with exercise than
CD4+ cells (60). CD8+ lymphocytes can directly kill foreign or infected cells,
whereas CD4+ are helper cells that mainly produce cytokines to magnify the immune
response. Also, memory lymphocytes are recruited into the circulation more so than
naïve lymphocytes (27). Memory cells are more likely than naïve cells to relocate to
non-lymphoid tissues or possible locations of infection, like the vasculature of the
skin, lung, liver, and gut.

The increases in epinephrine release and cardiac output associated with exercise are
thought to contribute to the exercise-induced leukocytosis through de-margination
from vascular pools and immune organs (26, 24, 80). The delayed increase in
neutrophils may be mediated by an increase in Granulocyte colony-stimulating factor
(G-CSF) more so than epinephrine or cardiac output (87). Epinephrine release in
response to submaximal exercise has been shown to be sex dependent, with males
demonstrating a greater release compared to mid-follicular females (11, 15, 34).
However, an overall greater expression of β2-adrenergic receptors on lymphocyte
have been found in women compared to men (84, 43). The majority of previous
research suggests there are no post exercise sex differences in leukocytes (49, 1),
lymphocytes (49, 1), natural killer cells (6, 48) monocytes (1) or neutrophils (1).
However, the above studies did not control for menstrual cycle phase, oral
contraceptives, or matching male and female subjects for activity or fitness level.
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In one of the few studies to examine immune cell changes that controlled for
menstrual phase, oral contraception, and fitness, Timmons et al showed that women
taking OC had a greater post exercise increase in lymphocytes and neutrophils
compared to men and non-OC users after 90 min of cycling at 65% of VO2max (75).
Women taking OC experienced cycle specific (follicular and luteal phases that
corresponded to triphasic OC) exercise induced changes in total leukocytes,
neutrophils, monocytes, and lymphocytes, whereas non OC users had no fluctuations
across the menstrual cycle. The increase in immune cells after exercise were greater
in OC users on days taking the pill, and these increases were always greater than the
post-exercise changes seen in men. There were no differences in total leukocytes,
neutrophils, and monocytes between men and regularly menstruating women not
taking OC. However, non-OC users had a greater post exercise increase in
lymphocytes than men. Taken together, this study demonstrated immune cell changes
between men and women that are specific to OC use. There was a greater increase in
immune cells after exercise in the high progesterone phase of women taking OC than
men and non OC using women. Also, non OC using women had more lymphocytes
circulating post exercise than men.

Since there were no changes in lymphocyte number across the menstrual cycle in
non-OC users, sex hormones probably do not account for sex differences. While the
authors corrected for exercise-induced changes in plasma volume, there was no
mention of correcting for contraceptive induced changes in plasma volume. Previous
research has found an increase in plasma volume in women taking OC (83). A

30

difference in plasma volume between woman taking OC and those who did not could
influence the results not only of the previous study, but also much of the preceding
literature.

Thus, with moderate to intense aerobic exercise, the circulating leukocyte populations
change dramatically. However, the majority of research suggests that there is no
difference between sexes in the leukocyte response to aerobic exercise. Currently,
Timmons et al is the only study to control for OC use, and the only study to show a
difference between men, OC, and non OC users. Future research is warranted.

Sex Differences in Natural Killer Cell Response to Exercise
Natural Killer (NK) cells are a subset of lymphocytes produced in the bone marrow
and are part of the innate immune system. NK cells kill virally infected cells or
tumor cells through direct cytolytic mechanisms, without activation. NK cells account
for 10-15% of circulating blood mononuclear cells. During exercise, NK cells are
transiently increased by 186- 344% of initial resting value, following both maximal
and sub-maximal bouts (63). NK cells are the most responsive leukocyte to exercise
due to their catecholamine sensitivity (25). The magnitude of increase in NK cells is
more responsive to the intensity than duration of exercise. Generally, NK cell
number and activity will decline only in intense exercise lasting at least 1 hour (58).
At rest, men have a higher NK cell activity despite no difference in NK cell numbers
than regularly menstruating women or women using OC. Women using OC had the
lowest NK cell activity (88). Furthermore, IL-1 release from monocytes, an activator
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of NK cell activity, has been shown to be both sex and menstrual phase dependent
(44).

Previous research supports the notion that there are no sex differences in NK cell
number or activity in response to incremental or continuous exercise (6, 48).
However, neither study controlled for menstrual phase or OC use. In contrast,
adolescent girls not taking OC and tested in the mid-follicular phase had a greater
increase in NK cell count than adolescent boys during (77) and after (78) cycling
exercise for 60 min at 70% VO2. Also, NK cell subset expression was significantly
different between sexes (77). NK cells can be divided into 2 unique groups: CD56dim,
representing 90% of the circulating NK cells, and CD56bright cells that are more
responsible for inflammation (13). The ratio of CD56dim: CD56bright have been shown
to play a role in reproduction as the concentration of NK cells in the uterine mucosa
changes across the menstrual cycle and with pregnancy (40). For an in depth review
of NK cell subset changes with exercise see Timmons, 2008 (74). NK cell activity
was not assessed in either study. Since results from Yovel 2001 (88) suggest there is
both a sex and OC effect on NK cell activity at rest, future controlled studies are
needed to quantify NK cell activity during and after exercise in an adult population.

Sex Differences in Neutrophil Response to Exercise
Neutrophils are a large subset of granulocytes, comprising ~90% of all granulocytes.
Granulocytes are characterized by the granules in their cytoplasm and consist also of
basophils and eosinophils. Neutrophils are members of the innate immune system.
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They are part of the acute inflammatory response and are the first cells recruited from
the blood to the site of injury or infection (5). Neutrophils attack microbes that have
entered the circulation by phagocytosing the microbe or releasing oxidative bursts to
destroy the pathogen. Neutrophils also produce cytokines to recruit more neutrophils
and other immune cells to the site of injury and enhance both specific and innate
immunity. Granulocytes are higher in the luteal phase compared to the follicular
phase (19) and have been shown to increase during pregnancy (82). There is
evidence that with pregnancy there is a decrease in cell-mediated immunity (36). As
a compensation mechanism, the pregnant women increase activity of the innate
system, most notably granulocytes.

Acute exercise causes a mild inflammatory response to repair damaged tissue, which
is characterized first by neutrophil infiltration, followed by macrophage infiltration
several hours later (23). While the current data on sex differences in neutrophil
infiltration after exercise are equivocal (45, 70, 71), generally females rats have a
blunted post exercise inflammatory response that leads to less neutrophils infiltrating
skeletal muscles and less muscle soreness (70, 72). From animal studies, it seems
that estrogen is limiting neutrophil infiltration by acting as a cell membrane stabilizer
and antioxidant. However, data from human studies are less compelling. For a review
of sex differences in neutrophil infiltration see Point – Counterpoint, Tiidus & Hubal
2009 (35, 73).

Higher numbers of circulating neutrophils were observed both at rest and after 90 min
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of cycle ergometry in women taking OC compared to men and non-users.
Furthermore, the greatest increase in neutrophils after exercise in OC users was seen
in the luteal phase when estradiol levels were lowest (75). Since estrogen has been
shown to inhibit the inflammatory response to exercise (70, 72), it makes sense that
neutrophils would be highest when estrogen was lowest. Previously, data from males
suggested that increased IL-6 levels during exercise lead to increases in cortisol,
which ultimately are responsible for exercise neutrophilia (68). However, data from
sex comparison studies suggest there is no correlation between IL-6 levels and
cortisol during exercise (75, 18). OC users had higher cortisol and neutrophil levels
compared to men and non-users, but equivalent resting and post exercise levels of IL6 (75). This could potentially highlight differences in regulation of anti-inflammatory
mediators between men and women and future research should be conducted to
understand this response.

Potential Mechanisms of Action for Sex Differences in Immune Response to Exercise
Given the post-exercise sex differences in immune function, estrogen may be
responsible for this disparity. However, results from a few well-controlled studies
suggest other physiologic variables account for the sex discrepancies. The sex
differences in IL-6 during maximal exercise could potentially be mediated by a
difference in the amount of adipose tissue (42). Mohamed-Ali showed that adipose
tissue released IL-6 (47). Furthermore, increases in catecholamines during exercise
are related to IL-6 release from adipose tissue (39). Thus, the greater IL-6 response
in women could be due to their greater fat content (18).

34

The disparity in post-exercise leukocyte and neutrophil responses between women
who took OC, non-OC users, and men could be related to differences in growth
hormone and cortisol levels. Both growth hormone (3) and cortisol levels (75) are
higher in women taking OC. Furthermore, both growth hormone (37) and cortisol
(14) have been shown to increase circulating neutrophil levels. However, in
Timmons et al (75), cortisol levels did not differ between menstrual cycle phases,
only between groups. Thus, cortisol alone could not be responsible for the increased
post exercise immune cell response of the OC users. Exercise induced leukocytosis
seen in both men and women appear to be associated with the increased circulating
catecholamines (60). Thus, as noted by Timmons et al, the greater increase in
lymphocytes in women during exercise may be due to their greater density of
lymphocyte β2-adrenergic receptors. (84, 43). Furthermore, the number of β2adrenergic receptors on lymphocytes decreases over 10 wks of aerobic training (62).
Thus differences in training also may be responsible for some of the sex differences
reported in studies that did not control for fitness.

Intact female mice had lower mortality rates to post-exercise HSV-1 inoculation
compared to males or ovariectomized females (8, 7). Yet, when estrogen was
replaced after ovariectomy, ovariectomized females were still more susceptible than
the intact group. Therefore, the authors concluded that physiologic doses of estrogen
(1µg/day) are not responsible for the enhanced immunity seen in intact female
animals. Further research is warranted to confirm this finding and to identify the
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cause for the greater immune response of the female animals. Similarly, 8 days of
supplementing men with estradiol had no effect on resting or post exercise cortisol,
IL-6, or neutrophil counts after 90 min of cycle ergometry at 60% of aerobic capacity
(76). This study reinforces the suggestion that estrogen alone is not responsible for
immune sex differences, and could potentially point to a difference in the expression
of estrogen receptors (ER) on cells throughout the body. Both males and females
have ERα and ERβ in skeletal muscle, with ERα mRNA 180 fold greater than ERβ
(86). Females exhibit greater ERα expression in the lungs than men (20), while ERβ
mRNA is higher on adipocytes in women (16). Taken together, these data suggests a
sex difference not only in ER quantities, but also a site-specific preferential
expression of ER isotypes.

Future Research Considerations and Conclusions
When menstrual phase and oral contraceptives are controlled, males and females
display marked differences in immune response to exercise (Table 1). Sex differences
in immune cell changes, cytokine alterations, along with morbidity and mortality are
apparent after submaximal and maximal aerobic exercise stressors. The primary
mechanism for many of the sex differences does not appear to involve the presence of
estrogen. Thus, future research should clarify which specific ovarian-related changes
are responsible for these immune response differences and their specific actions. By
using exercise to model the stress responses to certain clinical traumas, this avenue of
research may provide valuable insight into new approaches and sex-specific
treatments.
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Table 1. Gender differences in immune function in studies that controlled for
menstrual phase and OC use.
Author
N size
Exercise
Immune changes
Timmons, 2005

12 women (6 OC
users, 6 NOC users),
12 men

Northoff, 2008

9 women, 12 men

Brown, 2004

89 female mice, 86
male mice.

Brown, 2006

36 female mice, 36
male mice

Gonzalez, 1998

9 women

80 min walking,
32% VO2max in cold
(-5°C) environment.

25 girls, 33 boys

60 min cycling, 70%
VO2max.

Timmons, 2006a
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90 min cycling, 65 % 38% > lymphocyte
increase post
VO2max
exercise in NOC
women compared to
men.
60 min treadmill run, >Pro-inflammatory
gene expression in
93% AT
LP compared to men
or FP.
3 consecutive days
>morbidity for males
of treadmill running (28%) compared to
after HSV-1
females (16%).
inoculation until
volitional fatigue.
3 days of moderate
>macrophage
(90 min) or
antiviral resistance in
exhaustive
moderately exercised
(volitional fatigue)
females compared to
treadmill running
males.
after HSV-1
inoculation.
41% decrease in IL1β after exercise in LP
compared to FP. No
change in IL-6 or
TNFα.
>Leukocyte count at
30 & 60 min post
exercise in T5 boys
compared to T4/5
girls. >NK cell
response
immediately post
exercise in T4/5 girls
compared to T3/4
boys.

Table 1. (Cont.)
Timmons, 2006b

Ferrandez, 1999

11 girls, 11 boys.

60 min cycling, 70%
VO2max.

> Lymphocyte count
in girls at 30 min
(29%) and 60 min
(23%) of exercise.
CD56dim cells (105%
) and CD56dim
expressed as
proportions (67%)
greater in girls.
CD56bright cell counts
82% greater in girls
but not CD56bright
proportions.

60 female, 60 male
mice

Swimming until
exhaustion

>chemotaxis index
in females compared
to age matched male
mice

OC – oral contraceptive user. NOC non oral contraceptive user. LP – Luteal Phase.
FP- Follicular Phase. T5 – Tanner stage 5. T4/5 – Tanner stage 4 and 5.
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Abstract
This study evaluated possible sex differences in intracellular heat shock protein 72
(Hsp72), intracellular cytokines, and extracellular Hsp72 (eHsp72) before and after
exercise in the heat. Nine non-heat acclimated women (W) (age 23 ± 3, BF 21 ± 2%,
VO2max 58 ± 5 ml/kgFFM/min) and nine non-heat acclimated men (M) (age 25 ± 5, BF 12
± 5%, VO2max 60 ± 7 ml/kgFFM/min) completed 2 treadmill bouts at 60% VO2max for 60
min in a 42°C, 20% RH environment. The W had normal menstrual cycles and were
tested in counterbalanced order during follicular (fol) and luteal (lut) phases. M and W’s
duplicate trials were separated by 12 ± 2 days. Blood samples were drawn pre, 0, 1, and
4 hrs post-exercise. Mononucleated cells were analyzed for Hsp72, IL-1ra, IL-6, and
TNF-α using flow cytometry. eHsp72 was analyzed using ELISA. In trial 1, Hsp72
content increased in M by 37% 4 hrs post exercise (p<0.05), but did not change
significantly in W at any time after exercise. When Hsp72 expression was normalized to
baseline, M expressed greater Hsp72 than W (p<0.05) after exercise. Baseline Hsp72
increased by 26% in M from trial 1 to trial 2 (p<0.05), but this effect did not occur in W.
eHsp72 did not change after exercise, but there was a main effect for M having higher
levels than W (p<0.05). While cytokines did not change during exercise, W consistently
expressed less IL-1ra than M (p<0.05). IL-6 was higher in the fol than lut phase at 4 hrs
post exercise (p<0.05). Our findings suggest that unacclimated M and W differ in their
expression of Hsp72 and eHsp72 after exercise in the heat. M up-regulate Hsp 72 after a
single bout of exercise in the heat, which persisted for 12 days, suggesting an acquired
cellular thermotolerance. The inhibition of Hsp72 expression in W after exercise could be
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due to a known effect of estrogen to stabilize the cell membrane or to its action as an antioxidant.
Keywords: Heat shock protein, sex differences, thermoregulation, cytokines, immune
function
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Introduction
The cellular stress response is characterized by increased expression of intracellular heat
shock protein 72 (Hsp72). The actions of Hsp72 serve to fortify the cell against
perturbations by maintaining proper protein folding (13), inhibiting intracellular proinflammatory cytokine synthesis (5, 34, 35, 45), and limiting cellular apoptosis (34). The
expression of Hsp72 increases during (34) and after (9) exercise in the heat, and Hsp72
expression has been linked to heat tolerance (24). After heat exposure, baseline Hsp72
increases and cells are protected against normally lethal increases in core temperature
(19, 20).

Given that Hsp72 expression is up-regulated in response to stress, it is interesting that
animal studies have shown a difference in the expression of Hsp72 between sexes. Under
resting conditions, basal levels of Hsp70 in cardiac and renal tissue are higher in female
compared to male rats (10, 41). However, in response to running (28, 29) and
hyperthermia (36), male animals were able to express higher Hsp72 than females in the
gastrocnemius and cardiac tissue. In the above studies, ovariectomized females treated
with sham displayed similar post stress Hsp70 levels as males, while ovariectomized
females treated with estrogen showed decreased Hsp70 similar to intact females. An
increased basal expression of Hsp70 may reduce the response to stress and thus limit the
need for additional Hsp70 production after the stress (22). Little is known about sex
differences in Hsp72 expression in PBMC after exposure to heat.
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Currently, there are no human studies that have tested for possible sex differences in the
cellular stress response to exercise in the heat. Therefore, our purpose was to compare
the expression of Hsp72, circulating Hsp72 (eHsp72), and intracellular cytokines at rest
and after exercise in the heat in men (M) and women (W). Furthermore, we examined if
W in follicular (fol) and luteal (lut) phases of the menstrual cycle differ in their amount of
Hsp72, eHsp72 and intracellular cytokines expressed at rest and in response to exercise in
the heat.

Materials and Methods
Subjects
Eighteen (9 men and 9 women) active, but untrained subjects completed two treadmill
sessions in a hot, dry environment (42.3±1°C, 22.5 ±12% RH). M were matched with W
for fitness and age (Table 1). The W were followed for three months and demonstrated
regular menstrual cycles. They were not taking hormonal contraceptives. W were tested
in the fol (day 7±2) and lut (days 20±1) phases of their menstrual cycle. The same length
of time elapsed between the 2 exercise trials (M: 12 ±4 days, W: 12 ±2 days). The
University of New Mexico’s Institutional Review Board approved this protocol and the
subjects provided informed, written consent prior to participation.
Preliminary Testing
Body composition and cardiorespiratory fitness were assessed for all subjects. Three site
skinfold (Lange, Beta Technology, Santa Cruz, CA) measurements (M: chest, abdomen,
thigh; W: triceps, suprailiac, thigh) were used to determine percent body fat. Each site
was measured in triplicate and the mean value was used to calculate percent body fat. A
continuous graded treadmill test in a temperate room (22-24°C, 30% RH) was used to
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determine VO2peak. VO2peak was assessed through open circuit spirometry (ParvoMedics,
Sandy, UT) and defined as the highest 30 second value when 2 of the following criteria
were met: 1) a plateau in VO2 (change in VO2 <150 ml min-1) with increased workload,
2) a maximal respiratory exchange ratio greater than 1.1, and 3) heart rate greater than
95% of the age predicted maximum (220-age).
Experimental Design
Each subject performed 2 exercise trials (treadmill running at 60% VO2peak) in the heat
for 60 min. Female subjects were counterbalanced so that 4 subjects performed the first
exercise bout in the lut phase while 5 subjects performed the first exercise bout in the fol
phase. Fol testing was done between days 5-9 and lut testing occurred between days 1921. The onset of bleeding was considered day 1. Plasma estrogen and progesterone
values were obtained to corroborate the appropriate menstrual cycle phase (Genway
Bioscience, San Diego, CA).

Experimental Protocol
All subjects were un-acclimated to the heat and data collection took place during the fall
and winter months (October – February). Subjects were instructed to avoid exercise and
alcohol for 24 hrs and to avoid caffeine for 12 hrs prior to each exercise test. Subjects
were given a list of high carbohydrate foods to consume for dinner the night before the
test and for breakfast on the morning of the test. Subjects were asked to consume the
same foods for the second trial.
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On the day of the trial, nude body weight was recorded to the nearest 0.1kg (Seca Scale,
Birmingham, UK) and urine osmolality was used to assess hydration levels (Advanced
Osmometer, Model 303, Advanced Instruments Inc, Norwood, MA).
Core temperature (Tcore) was measured by inserting a thermistor (YSI precision 4400
Series, Yellow Springs Inc, Yellow Springs, OH) 10 cm past the anal sphincter. An
intravenous catheter was inserted in an antecubital vein and kept patent by infusing 3 ml
of isotonic saline every 15 min during and after the exercise bout. Samples were drawn
pre, immediately post, 1 hour post, and 4 hours post exercise. All blood was stored in
EDTA treated tubes (Vacutainer, Franklin Lakes, NJ) for future analysis.

The exercise intensity was set to elicit 60% of VO2peak. VO2 was measured every 15 min
during exercise. The workload was adjusted during the first 15 min of trial 1 to ensure
60% of VO2peak. After the first 15 min, the workload did not change. When subjects
repeated the exercise trial, the intensity was identical to the first exercise trial. During the
first exercise trial, subjects were allowed to drink water ad libitum. The subjects ingested
the same volume of water during their second trial. 1 male and 1 female subject was
unable to complete 60 min of exercise due to heat related issues. When the trial was
repeated, these subjects exercised for the same duration as in trial 1.
Blood Analysis
Hsp72
Three ml of blood was drawn at each time point. Half of the blood was aliquotted into
EDTA treated tubes and used to measure hematocrit, Hsp72, estrogen, and progesterone.
Hsp72 was quantified using flow cytometry. Briefly, cells were separated from 1 ml of
blood using density gradient centrifugation (15 min, 2100 RPM, 0 ACC) with 1.077 g/ml
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Histopaque (Sigma-Aldrich, St. Louis, MO). Peripheral blood mononucleated cells were
washed with PBS and then treated with Reagent A (Fix and Perm kit, Invitrogen,
Carlsbad, CA) and incubated at room temperature for 15 min. Cells were then washed
and treated with Reagent B (Fix and Perm kit, Invitrogen, Carlsbad, CA) combined with
a monoclonal Hsp72 FITC antibody (Assay Designs, Ann Arbor, MI) at 100 µg/ml.
Cells were incubated for 20 minutes in the dark at room temperature. Cells were washed
a final time, and then diluted in 300 µl sheath fluid and analyzed using a FACSCAN
cytometer (BD Scientific, San Jose, CA). Ten thousand events were collected. Data was
analyzed using Cellquest software (BD Scientific, San Jose, CA). The amount of protein
produced per cell population was quantified as mean fluorescent intensity (MFI). To
determine MFI, cells were gated and corrected for auto-fluorescence based upon
unstained control. The gating strategy is shown in figure 1 To serve as a positive control,
1 ml of post exercise blood was placed in a 42°C water bath for 2 hours.
Figure 1. Gating strategy: SSC vs FSC for PBMC. Expression of Hsp72 in unstained
cells, pre exercise, and after 42ºC incubation.

Cytokines
For cytokine analyses, 1.5 ml of blood was treated with 4.5µg Brefeldin A (ebiosciences,
San Diego, CA) then placed in EDTA treated tubes. The same protocol was used to
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quantify cytokine expression except that Reagent B (Fix and Perm kit, Invitrogen,
Carlsbad, CA) was combined with an APC conjugated monoclonal antibody for TNF-α
(concentration: 0.2 mg/ml), a FITC conjugated anti-human IL-1ra antibody (0.5 mg/ml),
and a PE conjugated anti-human IL-6 antibody (0.2 mg/ml). To determine MFI, cells
were gated and corrected for auto-fluorescence based upon unstained control. To serve as
a positive control, 1 ml of post exercise blood was treated with 1µg of LPS.

eHsp72
Plasma was analyzed for extracelluar Hsp72. Plasma was obtained after density gradient
centrifugation using 1.077 g/ml Histopaque (Sigma-Aldrich, St. Louis, MO). Plasma was
immediately stored in -80°C until future analysis. An Hsp72 ELISA kit (Assay Designs,
Ann Arbor, MI) was prepared according to manufacturer’s instruction to quantify
eHsp72. Minimum detection of eHsp72 was 0.20 ng/mL with an inter-assay precision of
12.8% and an intra-assay precision of 3.9%. Hematocrit was analyzed within 15 min of
the blood draw and used to correct for plasma volume changes with exercise as outlined
in Van Beaumont, 1972 (40). eHsp72 results are corrected for plasma volume changes
from the exercise bout.
Estrogen and Progesterone
Plasma was analyzed for estrogen and progesterone using EIA kits (Genway Bioscience,
San Diego, CA) according to manufacturer’s instruction. Minimum detectable
concentration of estradiol was 5 ± 2 pg/mL and 0.08 ± 0.03 ng/mL for progesterone.
Inter-assay variability was 6% for estradiol and 8.8% for progesterone. Intra-assay
variability was 4.6% for estradiol and 9.7% for progesterone.
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Statistical Analysis
To determine if Hsp72, eHsp72, or cytokines changed with exercise for a given
condition, a 1 factor (time) ANOVA was used to analyze each condition independently.
A total of 6 independent 1-way ANOVA’s were run. The conditions were: trials 1 and 2
for M (n = 9), trials 1 and 2 for W (n = 9), fol (n = 6), and lut (n = 6).
To analyze if there was an order effect, we compared trial 1 vs. trial 2 for the M (n=9)
and trial 1 vs. trial 2 for the W (n=9) using a 2 factor (time x trial) repeated measures
ANOVA.
To test for differences due to the menstrual cycle, a 2 factor (time x phase) repeated
measures ANOVA was used. Here we compared fol vs. lut data, n=6.

To test for sex differences in Hsp72, eHsp72, and cytokines, a 2 factor (time x condition)
ANOVA was used. In this analysis, we compared each condition (M trial 1, M trial 2, W
trial 1, W trial 2, fol, and lut) to all other conditions.

Baseline Hsp72 MFI on trial 1 was compared to baseline Hsp72 on trial 2 using a paired
t-test. This was done to assess acquired cellular thermotolerance.

Statistical analysis was performed by using SPSS version 16. Statistical significance was
set at α = 0.05. If the sphericity assumption was violated, the Huynh–Feldt correction
was applied to the degrees of freedom of the F ratio. When appropriate, Tukey’s post
hoc tests were performed. All data is expressed mean ± SD.
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Results
Subject characteristics. M and W differed significantly for height (p = 0.01), weight (p =
0.01), % body fat (p = 0.01), and aerobic capacity expressed as ml/kg/min (p = 0.03).
However, when aerobic capacity was expressed relative to fat free mass, there was no
difference between groups (Table 1). For M, trial 2 was repeated 12 ± 4 days after trial 1.
For W, trial 2 was repeated 12 ± 2 days after trial 1.

Table 1. Descriptive Data (n=9 women, 9 men) (Mean ± SD).
Age (yr) Height (cm) Weight (kg) VO2peak
VO2peak
(ml• kg-1 • (ml.• kg-1
min-1)
FFM • min1
)
Men
26±5
182± 7∗
81.0±15∗
52.6±8∗
60.0±7.7
Women 24±3
170±3
63.1±12
44.9±5
58.8±5.2
∗
difference (p < 0.05) between groups.

% Body
Fat

12.0±5.5∗
21.4±2.5

Exercise Response. M and W did not differ in starting or ending Tcore, HR, pre or post
urine osmolality, or relative exercise intensity. However, M had significantly greater
sweat rates than W (p =.01) (Table 2). 1 female subject experienced heat illness issues at
45 min on trial 1, and 1 male subject was forced to stop exercising for similar reasons at
30 min on trial 1. The second bout for both subjects was identical in duration and
intensity to the first bout. All other subjects completed 60 min of exercise.
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Table 2. Thermal and cardiovascular responses to exercise (Mean ± SD).
Pre Tc
End Tc Pre
Post
End
End
Sweat
(°C)
(°C)
Urine
Urine
HR
%VO2pk Rate
Osm
Osm
(ml/kg/ (ml/min)
(mOsm/ (mOsm/
min)
kg)
kg)
Women
37.25±.2 38.93±.5 459±333 407±255 161±12
59±4
15.6±7Ω
Combined
(n=9)
Fol
37.19±.1 39.06±.5 394±346 351±245 161±11
59±5
16.2±5Ω
(n=6)
Lut
37.34±.2 38.97±.4 516±287 464±235 162±10
60±3
15.0±8Ω
(n=6)
Men
Trial 1
37.04±.2 39.36±.3 532±298 520±266 162±17
57±4
29.1±11
(n=9)
Trial 2
36.99±.3 39.26±.1 442±317 547±307 158±16
58±5
26.4±13
(n=9)
Ω
p< 0.05 from Men’s Trial 1 & 2
Hormones during the Menstrual Phase. Three subjects were removed from only the
menstrual cycle analyses after examining their estrogen and progesterone values. In
these subjects, estrogen and/or progesterone values were not higher in the lut compared to
fol phase. Therefore, all menstrual phase analysis are shown with n = 6. Of the six
subjects analyzed for menstrual phase differences, four completed their first exercise trial
in the fol phase, and two subjects exercised in the lut phase first. Estrogen and
progesterone levels were significantly higher in the lut compared to fol phase (p = .01)
(Tables 2 and 3). There was no difference in starting or end of exercise Tcore, HR, or VO2
between phases.
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Table 3. Sex hormones and menstrual cycle phase (n = 6) (Mean ± SD).
Estrogen Progesterone Ending
% VO2max
Pre Tc (°C)
(pg/ml)
(ng/ml)
HR
Follicular
86±27*
.85±.64Ω
160±16
57±5
37.19±.1
Luteal
159±56
5.5±2.9
165±15
59±3
37.34±.2
*p< 0.05 from Lut; Ωp< 0.05 from Lut

End Tc (°C)
39.06±.5
38.97±.4

Effect of exercise on Hsp72 and cytokines. During exercise, intracellular protein content
of Hsp72 expressed as MFI increased in M trial 1 (p = 0.03) (Figure 2). Post hoc tests
revealed a significant difference between baseline and 4 hrs post exercise (p = 0.05).
Hsp72 did not increase in trial 2. M trial 1 and 2 showed a strong tendency towards
statistical significance (p = 0.06) (Figure 2). Pre Hsp72 MFI for the M in trial 2 was 26%
higher than pre trial 1 (p = 0.01) (Table 4).

Figure 2. Hsp72 Response to Exercise: Men’s trial 1 and 2.
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For W, MFI of Hsp72 did not change in trial 1 or trial 2 (Figure 3). There was no
difference between trial 1 and 2. Pre Hsp72 MFI for W trial 2 was not higher than pre
trial 2 (Table 4).

Figure 3. Hsp72 Response to Exercise: Women’s trial 1 and 2.

Table 4. Baseline Hsp72 content (MFI): Trial 1 vs Trial 2. Mean ± SD.
Basal Hsp72 Content
% Increase from Trial 1
Men’s trial 1
108 ± 31
Men’s trial 2
136 ± 49*
26%
Women’s trial 1
121 ± 34
Women’s trial 2
130 ± 58
7%
*p< 0.05 from Men’s Trial 1.
Hsp72 data was normalized to baseline to describe the percent increase observed with
exercise. Normalized Hsp72 increased in M trial 1 (p = 0.00). Post hoc tests revealed
significant increases from baseline after 1 (p = 0.00) and 4 hrs of exercise (p = 0.00).
During M trial 2, normalized Hps72 did not increase significantly from baseline. M trial 1
differed from M trial 2 (p = 0.00).
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Normalized Hsp72 increased from baseline in W trial 1 (p = 0.02), however, none of the
post hoc tests were significant. In W trial 2, normalized Hsp72 did not increase from
baseline. W trial 1 differed from W trial 2 (p = 0.00).
Cytokines and eHsp72 did not change with exercise.

Effect of sex on Hsp72 and cytokines. There was no difference between M and W trials,
including menstrual phase, on Hsp72 expressed as MFI. For normalized Hsp72, there
was a main effect for condition (p = 0.00). Post hoc test showed M trial 1 was
significantly different than W trial 1 (p = 0.00), fol (p = 0.00), and lut (p = 0.00) (Figure
4). M trial 2 was not different than W trial 2, fol, or lut.

Figure 4. Normalized change in Hsp72: Men vs Women – Trial 1.

eHsp72 expressed a main effect for condition (p = 0.05). Post hoc test showed M trial 1
was higher than W trial 1 (p = 0.05) (Figure 5).
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Figure 5. eHsp72 Sex Differences. Corrected for plasma volume change with exercise.

There was a main effect for condition for IL-1ra (p = 0.03). Post hoc test showed that M
trial 2 (p = 0.03) was significantly higher than fol. There was no difference between M
and W trial 1 and M and W trial 2 (Figure 6).

Figure 6. IL-1ra: Sex Differences.

There was no main effect for condition for TNF- α or IL-6.

62

Effect of menstrual phase on Hsp72 and cytokines. Hsp72 MFI did not change during
exercise in the fol or lut phase and the response was similar in both fol and lut phases.
Normalized Hsp72 was not different when exercise was done in the fol compared to lut
phase. Normalized Hsp72 did not change from baseline during exercise in fol or lut
phase. eHsp72 expression did not change with exercise in the lut or fol phase, and there
was no differences in eHsp72 expression between menstrual cycle phases.
IL-1ra did not change during exercise in the fol or lut phase and the response was similar
in both fol and lut phases.
W expressed higher IL-6 in the fol compared to lut phase (p = 0.03) (Figure 7). Paired t
test revealed a significant increase in fol at 4 hrs post exercise (p = 0.04). Exercise in the
fol phase and lut phase did not change IL-6.

Figure 7. IL-6 Menstrual Phase.
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W expressed higher TNF- α in the fol compared to lut phase (p = 0.01) (Figure 8). Paired
t test revealed a significant increase in fol at 4 hrs post exercise (p = 0.03). Exercise in the
fol phase and lut phase did not change TNF- α.

Figure 8. TNF-α Menstrual Phase.

Discussion
Our major finding is that W did not increase Hsp72 in response to exercise in the heat,
nor was baseline Hsp72 increased after trial 1(Figure 3). M expressed a greater cellular
stress response to exercise in the heat than W. This is evident by the fact that M
expressed greater Hsp72 than W. Furthermore, baseline Hsp72 content was up-regulated
by 26% from trial 1 to trial 2 in M (Table 4). This increase in baseline Hsp72 led to a
significant fall in post exercise Hsp72 when the trial was repeated after ~12 days (Figure
2). Thus, for a given level of stress, women had a lower cellular stress response than men.
These sex differences may highlight the pleiotropic effects of estrogen in mediating the
stress response to exercise in the heat.
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Hsp72
Hsp72 expression plays a significant role in maintaining cellular homeostasis during and
after stress (13, 42). While there have been numerous animal studies that have shown sex
differences in Hsp72 expression with hyperthermia, to our knowledge ours is the first
study to examine this effect in humans. Results from animal studies imply that estrogen is
responsible for increased baseline Hsp72 expression (3, 10, 41) and this up-regulation
exerts protective effects that limit Hsp72 production during stress (22, 28, 29, 36). In our
study in humans, baseline Hsp72 did not differ between sexes (Table 4). M expressed
increased Hsp72 4 hrs post exercise (Figure 2) and this is consistent with previous
findings (4, 9, 11, 26, 33) that have shown increased Hsp72 content within 4 hrs after a
stressor. In contrast, W did not increase Hsp72 (Figure 3). Further, M had higher
normalized Hsp72 compared to W in trial 1 (Figure 4). Thus, while it is understood that
M increase Hsp72 in response to stress, we report for the first time that W do not. The
lack of increase in Hsp72 could potentially demonstrate increased protection from
exercise in the heat exerted by estrogen, thereby inhibiting the need for additional Hsp72.

Acquired cellular thermotolerance occurs when a single exposure to a severe, but sublethal heat stress leads to protection against future, more severe heat exposure. This
process involves the increased expression of basal Hsp72 (19, 20) and leads to decreased
Hsp72 induction in response to a second exposure to heat (30). In this fashion, Hsp72 can
act as a marker for thermal history (33). Our data showed a 26% increase in baseline
Hsp72 content in M, but not in W (Table 4). Thus, it appears that Hsp72 is regulated
differently after an acute bout of exercise in the heat in un- heat acclimated M and W. To
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our knowledge, it has not been previously appreciated that baseline Hsp72 could be upregulated for 12 days after a single acute bout of exercise in the heat.

This paper also is the first to examine possible effects of the menstrual cycle on Hsp72
expression. If estrogen is responsible for the decreased Hsp72 induction during exercise,
then the variation of estrogen across the menstrual cycle could alter baseline or stress
induced Hsp72 expression. The mechanism behind the relationship between estrogen and
the blunted intracellular Hsp70 response to stress is currently not known. It was
suggested that estrogen mediates this effect through a nongenomic hormonal
pathway. Treating animals with tamoxifen, a known estrogen receptor agonist, caused
the same blunted post exercise Hsp70 expression as in ovariectomized animals treated
with 17β and 17α estradiol (28). Since tamoxifen, 17β, and 17α estradiol all suppress
the post exercise expression of Hsp70, researchers suggest that these estrogen related
compounds stabilize cell membranes and attenuate oxidative stress (44). Such an effect
could protect thermal sensitive cells against exercise-induced damage, and thereby result
in a blunted Hsp72 expression.

However, we found no difference in baseline or post-exercise Hsp72 content when W
exercised in the fol compared to the lut phase. Thus, while these unacclimated W did not
increase Hsp72 in response to exercise in the heat, and this inhibition has been theorized
to be mediated by estrogen (3, 28, 29, 36), the physiologic variations in estrogen and
progesterone in these women during the menstrual cycle may not be sufficient to alter
Hsp72 expression.
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Cytokines
Exercise results in a rise in extracellular pro- and anti-inflammatory cytokines. It is
known, however, that PBMC are not the main origin of circulating cytokines (18, 27, 31,
37, 38). Despite this, recent studies have demonstrated robust changes in cytokine gene
expression in PBMC after exercise (6, 16, 15, 30). Furthermore, inflammatory gene
expression is menstrual phase dependent (25). Therefore, we sought to determine if M
and W differed in the intracellular inflammatory response to stress. Hsp72 has been
shown to abrogate pro-inflammatory cytokine synthesis (TNF-α, IL-1), but has little
effect on IL-6 (8). While we found no change in cytokine expression with exercise in the
heat, cytokines were affected by menstrual phase and sex.
Our results demonstrate a menstrual phase effect on IL-6 as W expressed higher IL-6
after exercise in the follicular phase (Figure 7). This result is consistent with previous
work in which W who exercised in the fol phase up-regulated IL-6 mRNA in PBMC, but
with exercise in the lut phase, IL-6 mRNA was down-regulated (25). The change in IL-6
values between menstrual phases may be due to altered carbohydrate (CHO) oxidation
rates. Zderic et al found that whole body CHO oxidation during cycling at 70-90% of
lactic threshold for 50 min is higher in the fol phase (46). This higher rate of CHO
oxidation could have lead to a greater use of CHO. In response to low CHO availability,
IL-6 production will increase (18).

IL-1ra is a cytokine that exerts anti-inflammatory effects through binding to the IL-1
receptor thus inhibiting the biological activities of IL-1α and IL-1β. Circulating IL-6 can
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trigger the release of IL-1ra (39). Unlike IL-6, which is released from the skeletal muscle
with exercise (27), IL-1ra is released from PBMC’s (27). It appears that the increase in
post exercise IL-1ra mRNA and protein plays a vital, paradoxical role to limit the effects
of inflammation seen with exercise. However, we found that intracellular IL-1ra in
PBMC did not change with exercise. One reason for the lack of IL-1ra production in our
study could be due to hyperthermia. Previous work has shown that stress hormones limit
the intracellular cytokine production from monocytes (31). With exercise in the heat,
stress hormones are elevated (12) and could thus limit IL-1ra production. Our results are
consistent with Selkirk et al who found that classic monocyte’s (CD14++CD16-)
intracellular IL-1ra MFI was unchanged in response to walking in the heat until
exhaustion (34).

Contrary to our results, Northoff et al reported an increased IL-1ra mRNA synthesis after
exercise in the fol compared to lut phase (25). Further, PBMC have been shown to
release less (21) or the same amount (43) of IL-1ra during the lut compared to the fol
phase. Our results suggest IL-1ra does not change across the menstrual cycle, but that M
have higher IL-1ra than W in the fol, but not the lut phase (Figure 6).
Similar to IL-6, it appears that circulating immune cells are not responsible for the
increased serum TNF-α which accompanies strenuous exercise (37). Our data support
this theory, as there was no increase in intracellular TNF-α after exercise in PBMCs.
Hsp72 has been shown to inhibit TNF-α through the NF-κB pathway (5, 45). Despite the
smaller increase in Hsp72, M and W expressed similar amounts TNF-α. However, W had
higher TNF-α in the fol compared to lut phase (Figure 8). Previously, it was found that
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progesterone plays a role in inhibiting TNF-α mRNA and protein in macrophages (23).
This decrease in TNF-α occurred through progesterone’s ability to inhibit the Nf-Kb
pathway. Progesterone was significantly higher in the lut phase (Table 3) and potentially
limited TNF-α production. In addition, this highlights a different mechanism of TNF-α
regulation that could account for similar TNF-α values between M and W, despite
differences in Hsp72 expression.
eHsp
Another novel finding in this study was that the eHsp72 response was different between
M and W in trial 1 (Figure 5). eHsp72 values in W were almost half of M’s values.
Unlike intracellular Hsp72 that has been shown to down-regulate inflammatory
cytokines, eHsp72 stimulates pro-inflammatory cytokine release from monocytes (2).
eHsp72 has been linked to LPS tolerance (1) and may serves as a marker for heat illness
(32).
The release of eHsp72 is through an α1 adrenergic pathway (17). Epinephrine release in
response to submaximal exercise is greater in males compared to mid-fol females (7, 14).
Epinephrine was not measured in the current study, yet this could be a plausible
explanation for the greater eHSP in M than F. Future studies should address the different
eHsp72 response between M and W.
Conclusions
We found that un-acclimated M and W differ in the amount of Hsp72 expressed in
PBMC in response to exercise in the heat. M increased Hsp72 after 1 bout of exercise in
the heat, while W did not. For M, one bout of exercise in the heat increased basal Hsp72
content, suggesting acquired cellular thermal tolerance. W did not demonstrate this
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response. During trial 1, eHsp72 was higher in M. Despite these sex related differences
in Hsp72 expression, M and W do no differ in their ability to tolerate or acclimate to heat.
Thus, estrogen could provide cellular protection and thus decrease the need for Hsp72.
Though cytokines did not change with exercise, IL-6 and TNF-α were menstrual phase
dependent, while IL-1ra regulation could be dependent on sex.
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Chapter IV
Summary, Conclusions, and Recommendations
Summary: Hypotheses
1. Women will have higher basal levels of intracellular Hsp72 than men.
Our results showed that baseline Hsp72 in PBMC did not differ between
sexes. Future research should examine Hsp72 content in tissues to determine
baseline sex differences.

2. In response to a severe exercise stress (60 minutes of treadmill exercise at
60% VO2peak in the heat), men will express greater amounts of Hsp72.
Our data supports this hypothesis as men increased Hsp72 expression (MFI) 4
hrs post exercise, while women did not increase Hsp72. Furthermore,
normalized Hsp72 was significantly higher in men than women.

3. Intracellular Hsp72 levels will be higher at baseline in women during the
luteal phase of their menstrual cycles, but in response to severe exercise the
expression of Hsp72 will be blunted in luteal compared to the follicular phase.
Neither baseline nor post exercise Hsp72 levels were altered by menstrual
phase. Our results are supported by animal research (Nickerson 2006) that
showed no change in Hsp72 content after tail shock between phases of the
menstrual cycle. Thus, while it appears that estrogen is responsible for the
inhibition of Hsp72 after a stress, physiologic changes across the menstrual
cycle do not alter baseline or post stress Hsp72 expression.
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.
4. Pro-inflammatory cytokines (TNF-α) will be reduced in conditions where
intracellular Hsp72 is elevated.
Intracellular cytokines did not change in response to the exercise stress.
Catecholamine release is greater with exercise in the heat, and increase
catecholamines have been shown to inhibit pro-inflammatory in PBMC
(Rhind 2004). However, IL-1ra was higher in men compared to follicular
phase women. In addition, both TNF-α and IL-6 were higher in the follicular
compared to luteal phase.

5. There will be no difference between groups in eHsp72. eHsp72 is released
with exercise, but this process does not appear to be mediated by estrogen.
eHsp72 was significantly higher in males compared to females in trial 1. The
release of eHsp72 is through an α1 adrenergic pathway (Johnson 2005), and
epinephrine release in response to submaximal exercise is greater in men
(Davis 2000). Thus, the greater epinephrine release in men could potentially
explain the increased eHsp72 release in men compared to women.

Limitations
In this study Hsp72 was only assessed in PBMC’s and not in tissues as in most of the
animal studies. However, previous work in humans showed no difference between M
and W after 6 weeks aerobic conditioning in Hsp70 expression in the vastus lateralis
(Morton 2009). Unfortunately, baseline Hsp70 expression was not reported in this study.
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One potential reason for a blunted increase in Hsp72 in W may have been due to their
lower Tcore response during exercise. Although not statistically significant, W were ~
0.3°C cooler at the end of 60 min of exercise than M. This is most likely due to issues
with the rectal probe not reading appropriately or not being inserted to the proper depth.
Despite this difference, the M and W had similar cardiovascular and metabolic exercise
responses (Table 2). Previous work has shown that other factors such as oxidative stress
(Adrie 2000), energy depletion (Sciandra 1983), disruptions in calcium homeostasis
(Kiang 1994), and ischemia reperfusion injuries (Marber 1995) increase Hsp72. Finally,
all menstrual phase analyses were conducted with an n of 6. Therefore, it is plausible that
with a larger samples size and thus more power, changes in Hsp72 or cytokine expression
may emerge.

Conclusions and Applications
Our data demonstrates that in response to exercise in the heat, men express more Hsp72
than women. Also, men had higher eHsp72 values than women. Despite these sex related
differences in Hsp72 expression, men and women do no differ in their ability to tolerate
or acclimate to heat. Thus, estrogen could provide cellular protection and thus decrease
the need for Hsp72, highlighting a novel role of estrogen in conferring cellular
thermotolerance. Though cytokines did not change with exercise, IL-6 and TNF-α were
menstrual phase dependent, while IL-1ra regulation could be dependent on sex.
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Recommendations
Future research should examine sex differences in Hsp72 after repeated bouts of exercise
or during a heat acclimation process. Our data suggests that women are protected from
stressful stimuli without the need for additional Hsp72. It is our contention that estrogen
is mediating this protection. Therefore, studying the Hsp72 responses to exercise after
pharmaceutically inhibiting estrogen and progesterone release could reveal important
insights into cellular thermotolerance. Finally, it would be interesting to compare postmenopausal women to regularly menstruating women to determine the effect of age and
estrogen on Hsp72 expression.
.
Detailed Flow Cytometry Protocol
1. Blood that will be tested for cytokines must be treated with Brefeldin A (golgi
transport inhibitor). Add 3 µl of BFA/1 ml of blood. Thus, add 3 µl directly to EDTA
treated tubes for each ml of blood. From the beginning, you have to alliquot blood for
Hsp and blood for cytokines.
2. I separate the blood using Histopaque (1.077 Sigma-Aldrich), however there is a red
cell lysis that you can add directly to whole blood that is quicker and does not require
histopaque.
3. If using histopaque, spin 2100 RPM, 15 min, 0 ACC.
4. Remove plasma and store for extracellular proteins of interest.
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5. Remove buffy coat and place in a new 15 ml conical tube. Wash in 8 ml of cold PBS
(1300 RPM, 7 min, 6 ACC). Set aside 1 sample to use as the blank (unstained) control.
6. Remover supernatant.
7. Add 75 µl reagent A (from fix and perm kit - Invitrogen) to pellet to fix cells. Resuspend pellet and incubate 15 min at room temp. Don’t add reagent A to the blank
sample. Simply remove the supernatant and place in fridge until flow analysis.
8. Wash in 3 ml wash buffer (PBS, 10% FBS, and 1% NaN3). Spin 1200 RPM, 5 min, 6
ACC.
9. Remove supernatant.
10. Alliquot 75 µl reagent B (from fix & perm kit - Invitrogen) along with appropriate
amount of Hsp72 Ab (3 µl/ 106 cells – Hsp72 FITC – Assay Designs). Re-suspend pellet
and incubate in the dark 20 min.
Do the same for cytokines. 75 ul of reagent B mixed with appropriate volumes of IL-1ra
(1 µl/106 cells - eBioscience), IL-6 (2 µl/106 cells – eBioscience), and TNF-α (1 µl/106
cells – eBioscience) antibody. All antibodies are added to each sample. Re-suspend and
incubate in the dark for 20 min.
For isotype controls, each pellet can only be treated with one Ab. Thus, you need 4
different samples (one for Hsp72 isotype control, 1 for TNF isotype control, 1 for IL-6
isotype control, and one for IL-1ra isotype control). The isotype controls are added with
the same concentration as the corresponding Hsp72/cytokine antibody. Re-suspend and
incubate in the dark for 20 min.
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11. Wash 3 ml wash buffer.
12. Remover supernatant.
13. Re-suspend in 500 ml Sheath fluid.
14. Measure on Flow Cytometer.
15. To quantify MFI, gate on blank or isotype control. Use “median” statistic to quantify
intracellular protein content. Subtract blank MFI (for auto-flouresence) from median MFI
value.

80

References
1. Adrie C, Richter C, Bachelet M, et al. Contrasting effects of NO and
peroxynitrites on HSP 70 expression and apoptosis in human monocytes.
American Journal of Physiology. 279: C452-C460. 2000.
2. Davis SN, Galassetti P, Wasserman DH, and Tate D. Effects of gender on
neuroendocrine and metabolic counterregulatory responses to exercise in normal
man. Journal of Clinical Endocrinology and Metabolism. 85: 224–230, 2000.
3. Johnson J, Campisi J, Sharkey C, Kennedy S, Nickerson M, Fleshner M.
Adrenergic receptors mediate stress-induced elevations in extracellular Hsp72.
Journal of Applied Physiology. 99: 1789-95. 2005.
4. Kiang JG, Carr, FE, Burns MR, McClain DE. Hsp-72 synthesis is promoted by
increase in [Ca2+] or activation of G proteins but not pH or cAMP. American
Journal of Physiology. 267(7): C104-14. 1994.
5. Marber M, Mestril R, Chi S. et al. Over-expression of the rat inducible 70-kD
heat stress protein in a transgenic mouse increases the resistance of the heart to
ischemic injury. Journal of Clinical Investigations. 95: 1446-1456. 1995.
6. Morton JP, Holloway K, Woods P, Cable NT, Burniston J, Evans L, Kayani A,
McArdle A. Exercise training-induced gender-specific heat shock protein
adaptations in human skeletal muscle. Muscle Nerve. 39: 230-33. 2009.
7. Nickerson M., Kennedy SL, Johnson JD, Fleshner M. Sexual dimorphism of the
intracellular heat shock protein 72 response. Journal of Applied Physiology. 101:
566-575, 2006.
8. Rhind SG, Gannon GA, Shephard RJ, et al. Cytokine induction during exertional
hyperthermia is abolished by core temperature clamping: neuroendocrine
regulatory mechanisms. International Journal of Hyperthermia. 20(5): 503-16.
2004.
9. Sciandra J, Subjeck J. The effect of glucose on protein synthesis and
thermosensitivity in Chinese hamster ovary cells. Journal of Biological
Chemistry. 258: 12091-12093. 1983.

81

The University of New Mexico Health Sciences Center
Consent to Participate in Research
Gender difference in heat shock protein expression in response to acute exercise in the
heat
Introduction
You are being asked to participate in a research study that is being done by Dr.
Schneider, PhD, who is the Principal Investigator and her associates. from the
Department of Health, Exercise, and Sports Science. This research is studying the effect
of gender on heat shock protein expression in response to exercise in the heat.
Heat shock proteins (HSP) are a family of proteins that serve to protect the cell. HSP can
be found in all cells of the body. The activities of HSP are vital for cells to resist
environmental stressors like heat. Because of the protective nature of HSP, recent
research has implicated HSP in preventing damage to the heart.
You are being asked to participate in this study because HSP can increase protection from
stressors like exercise and heat, but animal studies suggest women produce less HSP in
response to stress than men. Therefore, if we can understand the reason behind this
response, it could potentially lead to better cell protection. 24 people (8 men and 16
women) will take part in this study at the University of New Mexico.
This form will explain the research study, and will also explain the possible risks as well
as the possible benefits to you. We encourage you to talk with your family and friends
before you decide to take part in this research study. If you have any questions, please
ask one of the study investigators.
What will happen if I decide to participate?
If you agree to participate, the following things will happen:
Your cardiovascular fitness will be assessed through a preliminary exercise trial (VO2
max test) where you will run on a treadmill while breathing into a mouthpiece.
Specifically, you will run until you become too tired to continue. During the test, we will
collect your expired air which allows us to calculate the amount of oxygen your body is
consuming. To collect your expired air, you will breathe through a sterile, rubber
mouthpiece and wear a nose-clip. This may cause you to experience some discomfort
(dry mouth) and you may feel confined. A heart rate monitor will be used to measure
your heart rate. This test will be done in a comfortable environment. You should have at
least an average value of aerobic fitness for your age and gender to qualify for this study.
We will calculate your fitness based upon the amount of oxygen you breath in during the
test.
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Your body composition will be assessed through hydrostatic weighing and skin fold
measurement. During hydrostatic weighing, we will weigh you on a normal scale, and
then also weigh you underwater.
We will take 3 skin fold measurements on your body: One on your upper arm, one by
your belly button, and one on your thigh. During the skin fold measurement, you will
feel a slight pinch for 1-2 seconds.
These measurements allow us to determine your body density, which we can use to find
your % body fat. Your percent body fat is the amount of fat that makes up your total
body weight.
Female subjects will exercise in both phases of the menstrual cycle. In the follicular
phase (before ovulation), estrogen is low. In the luteal phase (after ovulation), estrogen
and progesterone are high. Thus, by exercising in both phases of the cycle then we can
see what effect estrogen has on HSP. To determine the phase of the menstrual cycle,
females subjects will keep a record of the number of days of each menstrual cycle. The
start of bleeding is considered day one of the menstrual cycle. The exercise test for the
follicular phase will occur between days 2-4 of the menstrual cycle. The exercise test in
the Luteal phase will occur between days 22-25 of the menstrual cycle. To help
determine when ovulation occurs, female subjects will record their oral temperature each
day before getting out of bed. Males and females will be tested twice over the course of 4
weeks.
Females will not be involved in this study if they are using any form of hormonal
contraceptives, or have used them within the past three months. Also, females will not be
allowed to participate in this study if they are pregnant. Prior to each exercise trial,
female subjects will be given a pregnancy test. This involves subjects urinating on a
pregnancy detection kit. If the subject is pregnant, they will not be exercised and will not
participate in this study.
If you meet the criteria to be included in this study based upon the above assessments,
then the study will require you walk or jog in a hot (100° F, 37.78°C) environment until
you reach a temperature of 39.0 C (102.2° F). This should take 45-60 minutes. During
the exercise test we will measure:
-Core body temperature. This requires that you insert a small, sterile, rubber catheter 4
inches into your rectum.
-Heart rate. We will use a telemetric heart watch monitor which consists of a transmitter
belt worn around the chest and a receiver watch worn on your wrist.
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-Urine samples. One tablespoon of urine will be required prior to the exercise challenge
to check your hydration status. These samples will be coded, analyzed, and properly
disposed on the same day.
Skin Temperature. We will place a flat thermometer on your upper right arm, chest, right
thigh, and right calf to measure how hot your skin gets. They will be placed on top of
your skin and be held there with plastic.
-Blood samples. Twenty milliliters (approximately 1.35 tablespoons) of blood will be
drawn with a needle from an arm vein before, immediately after exercise, and 1, 4 and 24
hours after exercise. Each visit 7 tablespoons, or 100 ml of blood will be drawn. The
total experiment will require about ¾ of a cup, or 200 ml of blood. This will require a
catheter to be placed in your arm so we only have to insert the needle once per exercise
session. Every 15 minutes during exercise, we will prick your finger to get one drop of
blood. This will measure lactate and tell us how intensely you are exercising. This will
occur 3 times for each exercise trial.
How long will I be in this study?
Participation in this study will take a total of 10 hours over a period of two 24 hour
periods.
What are the risks or side effects of being in this study?
Every reasonable precaution will be taken to minimize risks during this study. As in any
testing situation, there are risks involved. Some of these risks include muscle soreness or
injury, heart attack (1 in every 10,000 exercise tests) or other heart events during the
exercise trials. The risk for healthy young people during exercise testing is much lower.
There may be some discomfort and feeling of confinement from the use of the
mouthpiece and nose clip.
•

During the cardiovascular fitness test you may experience a strong sense of fatigue,
fainting, breathlessness, psychological stress (i.e., panic). There may be some
discomfort and feeling of confinement from the use of the mouthpiece and nose clip.
During the exercise trials in the hot room, you may feel hot, sweaty, and tired.

•

Blood samples will be drawn from an arm vein (1 baseline blood sample, and a total
of 4 samples after the exercise). Blood sampling may cause minor pain and
discomfort from the needlestick and there is a slight risk of bruising or infection at the
site of sampling. Sterile equipment and standard procedures done by experienced
staff will be used to minimize these risks.
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•

Insertion of the rectal probe may lead to additional discomfort or feelings of
awkwardness during the exercise trail. You, the subject, will insert the probe.

•

There are risks of stress, emotional distress, inconvenience and possible loss of
privacy and confidentiality associated with participating in a research study.

There may be unforeseeable risks to subject or unforeseeable risks to embyro if
subject is pregnant or becomes pregnant before the end of the exercise testing.
For more information about risks and side effects, ask your study doctor.

What are the benefits to being in this study?
There are no direct benefits to you for participation in this study.
Your participation in this study will help us to determine if a gender difference in heat
shock protein is present in humans. Potential results from this study could lead to
methods for increasing protection for women against cardiovascular disease and certain
types of tumors.
What other choices do I have if I do not want to be in this study?
The only alternative is not participating in this study.
How will my information be kept confidential?
We will take measures to protect your privacy and the security of all your personal
information, but we cannot guarantee confidentiality of all study data. You will be given
a coded number to protect your identity. We will keep a link between your code and your
name. A link will be kept for the duration of the study and will be stored in a separate file
away from the data. This code is stored in a locked file cabinet in the investigator’s
office. The link will be destroyed at the end of data analysis.
Information contained in your study records is used by study staff. The University of
New Mexico Health Sciences Center Human Research Review Committee (HRRC) that
oversees human subject research will be permitted to access your records. There may be
times when we are required by law to share your information. However, your name will
not be used in any published reports about this study. A copy of this consent form will be
kept in your medical record.
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What are the costs of taking part in this study?
There is no cost to you for taking part in this study.
What will happen if I am injured or become sick because I took part in this study?
No commitment is made by the University of New Mexico Health Sciences Center
(UNMHSC) to provide free medical care or money for injuries to participants in this
study. If you are injured or become sick as a result of this study, UNMHSC will provide
you with emergency treatment, at your cost. It is important for you to tell your study
doctor immediately if you have been injured or become sick because of taking part in this
study. If you have any questions about these issues, or believe that you have been treated
carelessly in the study, please contact the Human Research Review Committee (HRRC)
at the University of New Mexico Health Sciences Center, Albuquerque, New Mexico
87131, (505) 272-1129 for more information.
Will I be paid for taking part in this study?
No. There is no form of compensation for participating in this study.
How will I know if you learn something new that may change my mind about
participating?
You will be informed of any significant new findings that become available during the
course of the study, such as changes in the risks or benefits resulting from participating in
the research or new alternatives to participation that might change your mind about
participating.
Can I stop being in the study once I begin?
Your participation in this study is completely voluntary. You have the right to choose not
to participate or to withdraw your participation at any point in this study without affecting
your future health care or other services to which you are entitled.
If you choose to withdraw from the study, please contact Trevor Gillum at (580) 3801486 or tgillum@unm.edu. Subjects will be removed from the study they fail to comply
with the standard, high carbohydrate diet, start taking vitamin supplements, or in the case
of women, do not maintain a normal menstrual cycle.
Whom can I call with questions or complaints about this study?
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If you have any questions, concerns or complaints at any time about the research study,
Dr. Schneider, PhD, or her associates will be glad to answer them at (505) 277-3795,
Monday through Friday 8:00-5:00. If you need to contact someone after business hours
or on weekends, please call (580) 380 1486 and ask for Trevor Gillum. If you would like
to speak with someone other than the research team, you may call the UNMHSC HRRC
at (505) 272-1129.

Whom can I call with questions about my rights as a research subject?
If you have questions regarding your rights as a research subject, you may call the
UNMHSC HRRC at (505) 272-1129. The HRRC is a group of people from UNM and
the community who provide independent oversight of safety and ethical issues related to
research involving human subjects. For more information, you may also access the
HRRC website at http://hsc.unm.edu/som/research/hrrc/.
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CONSENT
You are making a decision whether to participate in this study. Your signature below
indicates that you read the information provided (or the information was read to you). By
signing this consent form, you are not waiving any of your legal rights as a research
subject.
I have had an opportunity to ask questions and all questions have been answered to my
satisfaction. By signing this consent form, I agree to participate in this study. A copy of
this consent form will be provided to you.
____________________________
___________
Name of Adult Subject (print)
Date

____________________________
Signature of Adult Subject

.
________________________
INVESTIGATOR SIGNATURE
I have explained the research to the subject or his/her legal representative and answered
all of his/her questions. I believe that he/she understands the information described in this
consent form and freely consents to participate.
_________________________________________________
Name of Investigator/ Research Team Member (type or print)
_________________________________________________
___________________
(Signature of Investigator/ Research Team Member)
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Date

HEALTH HISTORY AND PHYSICAL ACTIVITY QUESTIONNAIRE
Name ___________________________________ D.O.B ___/___/___
Date___/___/___
Age____
Height ______
Ethnicity_______

Weight _______

Gender____

Sitting blood pressure _______________
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦
♦♦♦♦♦♦♦♦♦♦

MEDICAL HISTORY
Physical
injuries:_________________________________________________________________
_____
Limitations______________________________________________________________
_____________
Have you ever had any of the following problems? Please check all that apply.
Heart attack/Myocardial Infarction____
problems
_____
Chest pain or pressure
____
Arrhythmias/Palpitations
____
of breath
_____
Blurred Vision
____
Tingling/numbness in extremities ____
Gastrointestinal Ulcers _____

Heart surgery

____

Valve

Swollen ankles
Heart murmur

____
Dizziness
____
Shortness
Congestive heart failure
Abnormal anxiety ____
Palpitations
Leg cramps
____

_____

____ H
_____

Have you ever had any of the following? Please check all that apply.
Hepatitis/HIV
Rheumatic fever
Kidney/liver disease
>200 mg/dl
Diabetes (specify type)
mg/dl
Emphysema
mg/dl

_____
_____
_____
_____
_____
_____
_____
_____

mg/dl

_____

Depression
_____
High blood pressure_____
Obesity
_____

Cancer (specify type)
Thyroid problems
Total cholesterol

Asthma

_____

HDL cholesterol <35

Stroke

_____

LDL cholesterol >135
Trigylcerides>150

Do immediate blood relatives (biological parents & siblings only) have any of the
conditions listed above? If yes, list the problem, and family member age at diagnosis.
________________________________________________________________________
_______________
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_______
_____

Is your mother living? Y N
Is your father living? Y N

Age at death______ Cause___________________
Age at death______ Cause___________________

Do you currently have any condition not listed that may influence test results? Y

N

Details__________________________________________________________________
______________
________________________________________________________________________
______________
Indicate level of your overall health. Excellent ____ Good ____ Fair ____ Poor____
Are you taking any medications, vitamins or dietary supplements now?

Y

N

If yes, what are
they?___________________________________________________________________
_
Do you have allergies to any medications? If yes, what are they?
________________________________
Are you allergic to latex?

Y

N

Have you been seen by a health care provider in the past year?

Y

N

If yes, elaborate
_______________________________________________________________________
Have you had a prior exercise test?
were the results?

Y

N

If yes, when?______________ What

________________________________________________________________________
____________
Have you ever experienced any adverse effects during or after exercise (fainting,
vomiting, shock, palpitations, hyperventilation)? Y N If yes,
elaborate.________________________________________
________________________________________________________________________
____________
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦
♦♦♦♦♦♦♦♦♦♦

LIFESTYLE FACTORS
Do you now or have you ever used tobacco?
How long?___________
quitting______________

Y

N

Quantity____/day

If yes: type ________________
Years since

How often do you drink the following?
Caffeinated coffee, tea, or soda _______oz/day
_______oz/week
Beer _______oz/wk
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Hard liquor _______oz/wk

Wine

Indicate your current level of emotional stress. High____

Moderate ____

Low____

♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦
♦♦♦♦♦♦♦♦♦♦♦♦

PHYSICAL ACTIVITY/EXERCISE
Physical Activity
Minutes/Day (Weekdays)

Minutes/Day (Weekends)

______/______ average

______/_____ average

Do you train in any activity (eg. jogging, cycling, swimming, weight-lifting)?

Y

N
How well trained are you? _____________________________________________________________
Vigorous Exercise (>30 Minute sessions)
_________Minutes/hours a week
How many days/wk do you exercise or do vigorous work outside? _______ average
days/wk
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦
♦♦♦♦♦♦♦

WOMEN ONLY
Please check the response that most closely describes your menstrual status:
_____ Post-menopausal (surgical or absence of normal menstrual periods for 12 months)
_____ Eumenorrheic – Normal menstrual periods (~every 28 days)
_____ Amenorrheic – Absence of normal menstrual periods for at least 3 months
_____ Oligomenorrheic – Irregular menstrual periods with occasional missed cycles.

Measured Height (cm) _________________
BMI (kg/m2) ____________

Weight (kg)_______________

Blood Pressure (mmHg) _______/_______
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦
♦♦♦♦♦♦♦♦♦♦
Positive cardiovascular risk factors include:
1. Family history: Myocardial infarction, coronary revascularization or sudden death before
55 years in father or first degree male relative or before 65 in mother or first degree female
relative.
2. Current cigarette smoker or quit within the previous 6 months.
3. Hypertension: systolic blood pressure greater or equal to 140 mmHg or diastolic pressure
greater or equal to 90 mmHg, or on antihypertensive medication.
6. BMI>30 kg/m2
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7. Sedentary lifestyle: persons not participating in a regular exercise program or not
meeting the minimal physical activity recommendations for the US Surgeon General's
Report.
If subjects have two or more cardiovascular risk factors as outlined above, then will be
excluded from the study. Furthermore, subjects need to fall within the following criteria to
be included:
-Healthy, between the ages of 18 and 34 years*
-VO2max > 30 for women and > 35ml/kg FFM/min for men, as determined in our lab using a
graded, cycle protocol.
-Moderately active lifestyle (exercise vigorously at least 30 min, 3 times a week)
- Not pregnant or not trying to become pregnant
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